Status:
COMPLETED
The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection
Lead Sponsor:
Universitas Airlangga
Collaborating Sponsors:
Danone Institute International
Conditions:
Failure to Thrive
Infections
Eligibility:
All Genders
1-5 years
Phase:
NA
Brief Summary
Lactoferrin is an iron-binding glycoprotein of the transferrin family which is expressed and refers to it as a "red protein from milk". It is known that lactoferrin can modulate the overall immune res...
Detailed Description
Interventional study with a pre-, post-test design. After the subject were diagnosed with infection (tuberculosis/TB or urinary tract infection/ UTI), they will receive 400 kcal/day (96 g/day divided ...
Eligibility Criteria
Inclusion
- • Children aged 1 - 5 years were diagnosed with failure to thrive with infections (TB or UTI)
Exclusion
- Fluid retention
- Organomegaly
- Tumor mass
- Congenital abnormalities
- Cerebral Palsy
- Hormonal disorders and syndrome
- Drop out Criteria:
- • Lost contact
Key Trial Info
Start Date :
October 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05289674
Start Date
October 4 2021
End Date
June 30 2022
Last Update
October 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Husada Utama Hospital
Surabaya, East Java, Indonesia, 60131